Carumonam versus ceftazidime for urinary tract infections.
Carumonam is a new monobactam antibiotic with potent activity against gram-negative aerobes. To study the efficacy and safety of carumonam for treatment of complicated and uncomplicated urinary tract infections, 54 patients were randomized to therapy with either carumonam or ceftazidime. Of 42 patie...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1988
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172338/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3056245/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.7.1031 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|